GOSS
Gossamer Bio Inc
NASDAQ: GOSS · HEALTHCARE · BIOTECHNOLOGY
$0.37
+5.21% today
Updated 2026-04-30
Market cap
$81.79M
P/E ratio
—
P/S ratio
1.69x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$0 – $4
Volume
18.7M
Gossamer Bio Inc (GOSS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-0.6%
Last 4 quarters
Revenue YoY growth
+47.1%
Most recent quarter
EPS YoY growth
-40.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-0.9%
2026-03-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-13 | $-0.21 | -13.5% | $0.46 | $0.46 | -0.9% |
| 2025-11-05 | $-0.21 | -10.5% | $2.30 | $2.31 | +0.4% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.19 | $-0.21 | -13.5% | $13.80M | +47.1% |
| 2025-09-30 | $-0.19 | $-0.21 | -10.5% | $13.29M | +40.2% |
| 2025-06-30 | $-0.18 | $-0.17 | +5.8% | $11.49M | -88.0% |
| 2025-03-31 | $-0.19 | $-0.16 | +15.8% | $9.89M | — |
| 2024-12-31 | $-0.17 | $-0.15 | +10.7% | $9.38M | +38.3% |
| 2024-09-30 | $-0.15 | $-0.14 | +6.7% | $9.48M | — |
| 2024-06-30 | $0.23 | $0.22 | -4.3% | $95.84M | — |
| 2024-03-31 | $-0.19 | $-0.19 | +0.0% | — | — |
| 2023-12-31 | $-0.21 | $-0.21 | +0.0% | $6.78M | — |
| 2023-09-30 | $-0.26 | $-0.21 | +19.2% | — | — |
| 2023-06-30 | $-0.49 | $-0.45 | +8.2% | — | — |
| 2023-03-31 | $-0.53 | $-0.52 | +1.9% | — | — |
Frequently asked questions
Has Gossamer Bio Inc beaten earnings estimates?
Gossamer Bio Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -0.6% over the last 4 quarters.
How does GOSS stock react to earnings?
GOSS stock has moved an average of -0.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Gossamer Bio Inc's revenue growth rate?
Gossamer Bio Inc reported year-over-year revenue growth of +47.1% in its most recent quarter, with EPS growing -40.0% year-over-year.